FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study. The procedure was performed in February 2025 and yielded highly...
FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study....
HeartBeam, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, announced a strategic collaboration with AccurKardia, an innovator in...
Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for percutaneous vessel closure.
Vivasure’s device...
LEM Surgical, a developer of advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted...
FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study....
Perfuze announced it completed enrollment in its U.S. FDA investigational exemption (IDE) trial evaluating its stroke treatment. Galway, Ireland-based Perfuze also shared a new...
Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system.
The FUTURE-HF study evaluated the safety and feasibility...
Cala announced new results from multiple clinical studies further expanding the body of evidence for its TAPS therapy. TAPS (transcutaneous afferent patterned stimulation) therapy...
FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study....
HeartBeam, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, announced a strategic collaboration with AccurKardia, an innovator in...
Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for percutaneous vessel closure.
Vivasure’s device...
LEM Surgical, a developer of advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted...